Institutional investors purchased a net $34.0 million shares of TEVA during the quarter ended December 2016, and now own 60.67% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 638.4 Thousand shares of Teva Pharmaceutical
HEXAVEST, INC. Bought 310.2 Thousand shares of Teva Pharmaceutical
VANGUARD INVESTMENTS AUSTRALIA L... Bought 237.1 Thousand shares of Teva Pharmaceutical